Table 3.
The regression analyses for coronary lesion progression related to demographic and clinical factors and urbanization.
| Univariable | Multivariable | |||||
|---|---|---|---|---|---|---|
| 300 m Distance (28.3 Hectares) | ||||||
| Parameters | OR | 95% CI | p | OR | 95% CI | p |
| Demographic and clinical factors: | ||||||
| Sex | 1.01 | 0.39–2.64 | 0.979 | - | - | - |
| Age | 0.97 | 0.92–1.02 | 0.203 | - | - | - |
| BMI | 1.02 | 0.99–1.05 | 0.276 | - | - | - |
| HA | 1.75 | 0.69–4.42 | 0.236 | - | - | - |
| DM | 1.34 | 0.46–3.90 | 0.592 | - | - | - |
| Hyperlipidemia | 2.25 | 0.89–5.70 | 0.087 | 2.83 | 1.05–7.66 | 0.040 |
| CV disease | 1.65 | 0.50–5.47 | 0.409 | - | - | - |
| Coronary angiography: | ||||||
| Primary Gensini | 1.01 | 0.99–1.03 | 0.392 | - | - | - |
| Primary PCI | 1.71 | 0.62–5.03 | 0.286 | - | - | - |
| Time interval | 1.00 | 0.99–1.00 | 0.611 | - | - | - |
| Development: | ||||||
|
0.67 | 0.05–1.32 | 0.752 | - | - | - |
|
1.46 | 1.23–6.23 | 0.727 | - | - | - |
|
2.49 | 1.45–4.23 | 0.893 | - | - | - |
| 500 m Distance (78.5 Hectares) | ||||||
| Parameters | OR | 95% CI | p | OR | 95% CI | p |
| Demographic and clinical factors: | ||||||
| Sex | 1.01 | 0.39–2.64 | 0.979 | - | - | - |
| Age | 0.97 | 0.92–1.02 | 0.203 | - | - | - |
| BMI | 1.02 | 0.99–1.05 | 0.276 | - | - | - |
| HA | 1.75 | 0.69–4.42 | 0.236 | - | - | - |
| DM | 1.34 | 0.46–3.90 | 0.592 | - | - | - |
| Hyperlipidemia | 2.25 | 0.89–5.70 | 0.087 | 3.51 | 1.18–10.41 | 0.024 |
| CV disease | 1.65 | 0.50–5.47 | 0.409 | - | - | - |
| Coronary angiography: | ||||||
| Primary Gensini | 1.01 | 0.99–1.03 | 0.392 | 1.02 | 0.99–1.05 | 0.152 |
| Primary PCI | 1.71 | 0.62–5.03 | 0.286 | - | - | - |
| Time interval | 1.00 | 0.99–1.00 | 0.611 | - | - | - |
| Development: | ||||||
|
0.50 | 0.06–1.47 | 0.531 | 0.07 | 0.01–0.66 | 0.101 |
|
1.78 | 1.34–7.49 | 0.459 | - | - | - |
|
6.78 | 2.45–9.45 | 0.135 | - | - | - |
| 700 m Distance (153.9 Hectares) | ||||||
| Parameters | OR | 95% CI | p | OR | 95% CI | p |
| Demographic and clinical factors: | ||||||
| Sex | 1.01 | 0.39–2.64 | 0.979 | - | - | - |
| Age | 0.97 | 0.92–1.02 | 0.203 | - | - | - |
| BMI | 1.02 | 0.99–1.05 | 0.276 | - | - | - |
| HA | 1.75 | 0.69–4.42 | 0.236 | - | - | - |
| DM | 1.34 | 0.46–3.90 | 0.592 | - | - | - |
| Hyperlipidemia | 2.25 | 0.89–5.70 | 0.087 | 4.24 | 1.34–13.39 | 0.014 |
| CV disease | 1.65 | 0.50–5.47 | 0.409 | - | - | - |
| Coronary angiography: | ||||||
| Primary Gensini | 1.01 | 0.99–1.03 | 0.392 | 1.02 | 1.0–1.05 | 0.112 |
| Primary PCI | 1.71 | 0.62–5.03 | 0.286 | - | - | - |
| Time interval | 1.00 | 0.99–1.00 | 0.611 | - | - | - |
| Development: | ||||||
|
0.59 | 0.02–1.23 | 0.747 | 0.03 | 0.00–0.49 | 0.025 |
|
2.56 | 1.67–4.87 | 0.535 | - | - | - |
|
12.67 | 2.45–16.56 | 0.113 | - | - | - |
Abbreviations: BMI—body mass index, CI—confidence interval, COPD—chronic obstructive pulmonary disease, CV—cardiovascular, HA—arterial hypertension, DM—diabetes mellitus, OR—odds ratio, PCI—percutaneous intervention.